Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 1, 2007, Pages 88-93

  Hoon Chung, Hyun ^a   Jun Kang, Won ^a   Weon Kim, Jae ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Chung, June Key ^a   Kang, Soon Beom ^a   Lee, Hyo Pyo ^a  

^a Seoul National University   (South Korea)

Author keywords

Cervical cancer; Ovary; PET CT; Transposition

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL MASS; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OVARY FUNCTION; OVARY TRANSPOSITION; PELVIS; POSITRON EMISSION TOMOGRAPHY; PREMENOPAUSE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER;

ADULT; FEMALE; FERTILITY; FLUORODEOXYGLUCOSE F18; HUMANS; HYSTERECTOMY; MEDICAL RECORDS; NEOPLASM STAGING; OVARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33845785167     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340601033626     Document Type: Article

References (25)

1. Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74:743-8.
2. Newbold R, Safrit H, Cooper C. Surgical lateral ovarian transposition: CT appearance. AJR Am J Roentgenol. 1990;154:119-20.
3. Goldberg RE, Sturgeon JF. Surgically transposed ovary presenting as an intraperitoneal mass on computed tomography. Can Assoc Radiol J. 1995;46:229-30.
4. Kier R, Chambers SK. Surgical transposition of the ovaries: imaging findings in 14 patients. AJR Am J Roentgenol. 1989;153:1003-6.
5. Bashist B, Friedman WN, Killackey MA. Surgical transposition of the ovary: radiologic appearance. Radiology. 1989;173:857-60.
6. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199-206.
7. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-7.
8. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology. 2002;225:575-81.
9. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77; quiz 150-1.
10. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med. 1999;26:1363-78.
11. Belinson JL, Doherty M, McDay JB. A new technique for ovarian transposition. Surg Gynecol Obstet. 1984;159:157-60.
12. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-9.
13. McCall CM, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol 1958; 75: 590-600; discussion -5.
14. Le Floch O, Donaldson SS, Kaplan HS. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer. 1976;38:2263-8.
15. Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology. 1970;96:175-80.
16. Thomas PR, Winstanly D, Peckham MJ, Austin DE, Murray MA, Jacobs HS. Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br J Cancer. 1976;33:226-31.
17. Hunter MC, Glees JP, Gazet JC. Oophoropexy and ovarian function in the treatment of Hodgkin's disease. Clin Radiol. 1980;31:21-6.
18. Anderson B, LaPolla J, Turner D, Chapman G, Buller R. Ovarian transposition in cervical cancer. Gynecol Oncol. 1993;49:206-14.
19. Chambers SK, Chambers JT, Holm C, Peschel RE, Schwartz PE. Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecol Oncol. 1990;39:155-9.
20. Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol. 1995;56:3-7.
21. Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol. 2001;82:504-9.
22. Yamamoto R, Okamoto K, Yukiharu T, Kaneuchi M, Negishi H, Sakuragi N, et al. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol. 2001;82:312-6.
23. 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma. AJR Am J Roentgenol. 2005;185:1057-9.
24. 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging. 2005;32:757-63.
25. 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging. 2005;32:549-56.